Andrea S. Blevins Primeau, PhD, MBA

Long-term historical exposure to air pollution is associated with an increased risk of breast cancer, a new study suggests.

Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.

Divarasib produced responses in patients with non-small cell lung cancer, colorectal cancer, and other solid tumors in a phase 1 trial.

Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.

Vitamin D3 supplementation may improve relapse-free survival in certain patients with gastrointestinal tract cancers, data suggest.

Active smoking is associated with shorter overall survival in pancreatic cancer patients treated with neoadjuvant FOLFIRINOX, a study suggests.

Proton therapy is associated with better outcomes than photon therapy in patients with esophageal cancer, according to a meta-analysis.

First-line cemiplimab confers durable survival benefits in patients with advanced non-small cell lung cancer, data suggest.

Withholding chemotherapy in first-line treatment does not compromise overall survival in HER2+ advanced breast cancer, according to researchers.

Patients with advanced melanoma who receive T-VEC prior to surgery have better long-term outcomes than patients treated with surgery alone, updated data suggest.